From: Quantitative proteomics by iTRAQ-PRM based reveals the new characterization for gout
Items | Control (N = 8) | Acute Gout (N = 8) | Gout Remission (N = 7) | Asymptomatic Hyperuricemia (N = 7) |
---|---|---|---|---|
Male(n) | 2 | 8 | 6 | 6 |
Age (year) | 28.38 ± 1.97 | 50.13 ± 3.92* | 44.57 ± 7.19 | 38.57 ± 6.34 |
Serum UA (μmol/L) | 273.0 ± 19.90 | 550.3 ± 45.17*** | 498.1 ± 55.78*** | 509.2 ± 19.53*** |
SCr (μmol/L) | 59.86 ± 5.60 | 86.44 ± 6.92 | 106.8 ± 19.84* | 107.5 ± 12.09* |
BUN (mmol/L) | 4.49 ± 0.24 | 4.80 ± 0.41 | 5.40 ± 1.14 | 5.93 ± 0.53 |
TC (mmol/L) | 4.81 ± 0.13 | 4.21 ± 0.31 | 4.00 ± 0.21 | 4.64 ± 0.39 |
TG (mmol/L) | 0.74 ± 0.05 | 1.84 ± 0.37 | 1.80 ± 0.22 | 2.33 ± 0.67* |
HDL-C (mmol/L) | 1.80 ± 0.10 | 0.95 ± 0.075*** | 0.98 ± 0.08*** | 1.18 ± 0.14*** |
LDL-C (mmol/L) | 2.42 ± 0.08 | 2.42 ± 0.25 | 2.28 ± 0.26 | 2.64 ± 0.38 |
Hypertension(n) | 0 | 3 | 3 | 2 |